Table 6.
Variable | EGFR mutation status | P | |
---|---|---|---|
19 deletion (n = 41) | L858R (n = 54) | ||
Diameter (mm) | 19.46 ± 5.61 | 19.51 ± 6.43 | 0.965 |
Shape | |||
Round/oval | 8 | 16 | 0.261 |
Irregular | 33 | 38 | |
Border definition | |||
Well defined | 23 | 29 | 0.816 |
Poorly defined | 18 | 25 | |
Margins | |||
Smooth | 12 | 25 | 0.092 |
Lobulated/spiculated | 29 | 29 | |
Cavitation/bubble‐like lucency | |||
+ | 10 | 13 | 0.972 |
− | 31 | 41 | |
Air bronchogram | |||
+ | 12 | 21 | 0.329 |
− | 29 | 33 | |
Thickening of the adjacent pleura | |||
+ | 5 | 8 | 0.713 |
− | 36 | 46 | |
Pleural retraction | |||
+ | 25 | 26 | 0.214 |
− | 16 | 28 | |
Vascular convergence | |||
+ | 8 | 7 | 0.386 |
− | 33 | 47 | |
Lymphadenopathy | |||
+ | 8 | 6 | 0.253 |
− | 33 | 48 | |
GGO proportion | |||
GGO negative | 25 | 32 | 0.866 |
Any GGO | 16 | 22 | |
Lobe | |||
Upper lobes | 33 | 51 | 0.229 |
Lower lobes | 17 | 16 |
CT, computed tomography; EGFR, epidermal growth factor receptor; GGO, ground‐glass opacity.